ES8502865A1 - Procedimiento para producir una composicion farmaceutica nasal mejorada. - Google Patents

Procedimiento para producir una composicion farmaceutica nasal mejorada.

Info

Publication number
ES8502865A1
ES8502865A1 ES519450A ES519450A ES8502865A1 ES 8502865 A1 ES8502865 A1 ES 8502865A1 ES 519450 A ES519450 A ES 519450A ES 519450 A ES519450 A ES 519450A ES 8502865 A1 ES8502865 A1 ES 8502865A1
Authority
ES
Spain
Prior art keywords
medicinal composition
nasal administration
nasal
agent
function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES519450A
Other languages
English (en)
Spanish (es)
Other versions
ES519450A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8502865A1 publication Critical patent/ES8502865A1/es
Publication of ES519450A0 publication Critical patent/ES519450A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES519450A 1982-02-01 1983-02-01 Procedimiento para producir una composicion farmaceutica nasal mejorada. Granted ES519450A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (2)

Publication Number Publication Date
ES8502865A1 true ES8502865A1 (es) 1985-02-01
ES519450A0 ES519450A0 (es) 1985-02-01

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
ES519450A Granted ES519450A0 (es) 1982-02-01 1983-02-01 Procedimiento para producir una composicion farmaceutica nasal mejorada.

Country Status (27)

Country Link
JP (1) JPS58134017A (pt)
AT (1) AT385656B (pt)
AU (1) AU565613B2 (pt)
BE (1) BE895750A (pt)
CA (1) CA1197783A (pt)
CH (1) CH653555A5 (pt)
DE (1) DE3302949A1 (pt)
DK (1) DK164771C (pt)
ES (1) ES519450A0 (pt)
FI (1) FI81258C (pt)
FR (1) FR2539994B1 (pt)
GR (1) GR81320B (pt)
HK (1) HK59989A (pt)
HU (1) HU191512B (pt)
IE (1) IE54532B1 (pt)
IL (1) IL67822A (pt)
IT (1) IT1197558B (pt)
KE (1) KE3888A (pt)
LU (1) LU84613A1 (pt)
MY (1) MY8700766A (pt)
NL (1) NL192325C (pt)
NZ (1) NZ203117A (pt)
PH (1) PH22198A (pt)
PT (1) PT76166B (pt)
SE (1) SE454402B (pt)
SG (1) SG34389G (pt)
ZA (1) ZA83673B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
CN111936140A (zh) * 2018-01-05 2020-11-13 英倍尔药业股份有限公司 通过精密鼻装置的双氢麦角胺的鼻内递送

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
IT8347646A0 (it) 1983-02-01
IL67822A (en) 1988-02-29
JPH0253406B2 (pt) 1990-11-16
AU565613B2 (en) 1987-09-24
KE3888A (en) 1989-09-01
IT1197558B (it) 1988-12-06
FR2539994B1 (fr) 1986-10-10
NL192325B (nl) 1997-02-03
DK164771B (da) 1992-08-17
CA1197783A (en) 1985-12-10
FI830245A0 (fi) 1983-01-25
IE830187L (en) 1983-08-01
DE3302949A1 (de) 1983-08-11
BE895750A (fr) 1983-08-01
PH22198A (en) 1988-06-28
AU1085083A (en) 1983-08-11
ATA30383A (de) 1987-10-15
SG34389G (en) 1989-09-22
MY8700766A (en) 1987-12-31
SE454402B (sv) 1988-05-02
DK164771C (da) 1992-12-28
PT76166A (en) 1983-02-01
FI81258B (fi) 1990-06-29
NZ203117A (en) 1986-12-05
NL8300325A (nl) 1983-09-01
LU84613A1 (fr) 1983-09-08
JPS58134017A (ja) 1983-08-10
DK38183D0 (da) 1983-01-31
CH653555A5 (de) 1986-01-15
DE3302949C2 (pt) 1992-05-21
AT385656B (de) 1988-05-10
NL192325C (nl) 1997-06-04
DK38183A (da) 1983-08-02
SE8300495L (sv) 1983-08-02
FR2539994A1 (fr) 1984-08-03
SE8300495D0 (sv) 1983-01-31
ZA83673B (en) 1984-09-26
GR81320B (pt) 1984-12-11
FI81258C (fi) 1990-10-10
IE54532B1 (en) 1989-11-08
PT76166B (en) 1986-02-04
HU191512B (en) 1987-02-27
FI830245L (fi) 1983-08-02
HK59989A (en) 1989-08-04
ES519450A0 (es) 1985-02-01
IL67822A0 (en) 1983-06-15

Similar Documents

Publication Publication Date Title
MX9700034A (es) Formulacion para la aplicacion por inhalacion.
GB9425160D0 (en) Medicaments
NZ226557A (en) Pharmaceutical compositions for the intranasal administration of a biologically active polypeptide in powder form and process for their preparation
DE3067536D1 (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof
HK1036940A1 (en) Nicotine inhaler.
ZA888461B (en) Azelastine-containing medicaments for application in the nose and/or at the eye
HK1004521A1 (en) Composition in the form of a foam containing 5- aminosalicylic acid for intrarectal administration
ATE77947T1 (de) Pentamidin enthaltende pharmazeutische zusammensetzungen.
CA2628857A1 (en) Formulation and method for treating neoplasms by inhalation
JPS57154122A (en) Administration vehicle for coadministration of drug and percutaneous absorption promoting agent
NZ225242A (en) Pad printing process for manufacturing a pharmaceutical presentation and/or dosage form for active ingredients of drugs
HUT41644A (en) Process for producing therapeutic preparation suitable for transdermic treating
PT76314A (en) Process for the preparation of biologically active polysaccharide concentrates and of pharmaceutical and cosmetic compositions containing them
ES8801130A1 (es) Metodo para la produccion de un sistema de aplicacion endonasal
EP0177342A3 (en) Oral formulation of therapeutic proteins
DE3068803D1 (en) The use of 2-phenyltetralin derivatives, or heterocyclic analogues, in medicine and pharmaceutical compositions containing them
WO2002024261A3 (en) Shock wave aerosolization apparatus and method
ES8502865A1 (es) Procedimiento para producir una composicion farmaceutica nasal mejorada.
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
HUP0002533A2 (hu) Asztmaellenes gyógyszerhatóanyagok új kombinációja
EP0271151A3 (en) Azumolene dosage form
Salorinne et al. Ventilation effects of fenoterol powder and freon-propelled aerosol in patients with asthma
JPS6456615A (en) Remedy for nephropathy
IE45282L (en) Pharmaceutical tablet formulation
JPS5462327A (en) Remedy for dna virus infectious disease

Legal Events

Date Code Title Description
PC1A Transfer granted